PSEUDOADDICTION REVISITED: A Commentary on Clinical and Historical Considerations

• Weissman DE , HaddoxJD: Opioid pseudoaddiction – an iatrogenic syndrome.Pain36(3) , 363–366 (1989).
   PubMed Web of Science ®Google Scholar
• Cherny NI , PortenoyRK: Cancer pain management. Current strategy.Cancer72(Suppl. 11) , 3393–3415 (1993).
   PubMed Web of Science ®Google Scholar
• Gonzales GR , PortenoyRK: Selection of analgesic therapies in rheumatoid arthritis: the role of opioid medications.Arthritis Care Res.6(4) , 223–228 (1993).
   PubMedGoogle Scholar
• Portenoy RK : Therapeutic use of opioids: prescribing and control issues.NIDA Res. Monogr.131 , 35–50 (1993).
   PubMedGoogle Scholar
• Portenoy RK : Tolerance to opioid analgesics: clinical aspects.Cancer Surv.21 , 49–65 (1994).
   PubMedGoogle Scholar
• Portenoy RK : Opioid therapy for chronic nonmalignant pain: a review of the critical issues.J. Pain Symptom Manage.11(4) , 203–217 (1996).
   PubMed Web of Science ®Google Scholar
• Knotkova H , FinePG, PortenoyRK: Opioid rotation: the science and the limitations of the equianalgesic dose table.J. Pain Symptom Manage.38(3) , 426–439 (2009).
   PubMed Web of Science ®Google Scholar
• Ballantyne JC , MaoJ: Opioid therapy for chronic pain.N. Engl. J. Med.349(20) , 1943–1953 (2003).
   PubMed Web of Science ®Google Scholar
• Rauck RL : What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review.Pain Pract.9(6) , 468–479 (2009).
   PubMed Web of Science ®Google Scholar
• Boudreau D , Von Korff M, Rutter CM et al.: Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol. Drug Saf.18(12) , 1166–1175 (2009).
   PubMed Web of Science ®Google Scholar
• Lawlor PG , BrueraE: Side-effects of opioids in chronic pain treatment.Curr. Opin. Anaesthesiol.11(5) , 539–545 (1998).
   PubMedGoogle Scholar
• Wirz S , WartenbergHC, ElsenC, WittmannM, DiederichsM, NadstawekJ: Managing cancer pain and symptoms of outpatients by rotation to sustained-release hydromorphone: a prospective clinical trial.Clin. J. Pain22(9) , 770–775 (2006).
   PubMed Web of Science ®Google Scholar
• Zimmermann C , SeccarecciaD, BoothCM, CottrellW: Rotation to methadone after opioid dose escalation: how should individualization of dosing occur?J. Pain Palliat. Care Pharmacother.19(2) , 25–31 (2005).
   PubMedGoogle Scholar
• Coluzzi F , Pappagallo M; National Initiative on Pain Control: Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy. Minerva Anestesiol.71(7–8) , 425–433 (2005).
   PubMedGoogle Scholar
• Fine PG : Opioid insights: opioid-induced hyperalgesia and opioid rotation.J. Pain Palliat. Care Pharmacother.18(3) , 75–79 (2004).
   PubMedGoogle Scholar
• Passik SD , KirshKL: Will the number of milligrams of an opioid dose ever re-achieve the truly meaningless status it deserves?J. Pain Palliat. Care Pharmacother.21(1) , 39–41 (2007).
   PubMedGoogle Scholar
• Passik SD , KirshKL, WhitcombLA et al.: A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy.Clin. Ther.26(4) , 552–561 (2004).
   PubMed Web of Science ®Google Scholar
• Passik SD , KirshKL, WhitcombLA et al.: Monitoring outcomes during long-term opioid therapy for non-cancer pain: results with the pain assessment and documentation tool.J. Opioid Manag.1(5) , 257–266 (2005).
   PubMedGoogle Scholar
• Passik SD , WeinrebHJ: Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids.Adv. Ther.17 , 70–80 (2000).
   PubMed Web of Science ®Google Scholar
• Webster LR , WebsterRM: Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.Pain Med.6(6) , 432–442 (2005).
   PubMed Web of Science ®Google Scholar
• Fleming MF , BalousekSL, KlessigCL, MundtMP, BrownDD: Substance use disorders in a primary care sample receiving daily opioid therapy.J. Pain8(7) , 573–582 (2007).
   PubMed Web of Science ®Google Scholar
• Passik SD , KirshKL, WhitcombLA, DickersonP, TheobaldDE: Pain clinicians‘ rankings of aberrant drug-taking behaviors.J. Pain Palliat. Care Pharmacother.16(4) , 39–49 (2002).
   PubMedGoogle Scholar
• Marks RM , SacharEJ: Undertreatment of medical inpatients with narcotic analgesics.Ann. Intern. Med.78 , 173–181 (1973).
   PubMed Web of Science ®Google Scholar
• Weissman DE : Understanding pseudoaddiction.J. Pain Symptom Manage.9(2) , 74 (1994).
   PubMed Web of Science ®Google Scholar
• Weissman DE : Pseudoaddiction #69.J. Palliat. Med.8(6) , 1283–1284 (2005).
   PubMed Web of Science ®Google Scholar
• Pappagallo M : The concept of pseudotolerance to opioids.J. Pharm. Care Pain Symp. Control6 , 95–98 (1998).
   Google Scholar
• Forbes K : Opioids: beliefs and myths.J. Pain Palliat. Care Pharmacother.20(3) , 33–35 (2006).
   PubMedGoogle Scholar
• Heit HA : The truth about pain management: the difference between a pain patient and an addicted patient.Eur. J. Pain5(Suppl. A) , 27–29 (2001).
   PubMed Web of Science ®Google Scholar
• Kirsh KL , WhitcombLA, DonaghyK, PassikSD: Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study.Clin. J. Pain18(4 Suppl) , S52–S60 (2002).
   PubMed Web of Science ®Google Scholar
• Kowal N : What is the issue?: pseudoaddiction or undertreatment of pain.Nurs. Econ.17(6) , 348–349 (1999).
   PubMed Web of Science ®Google Scholar
• Weaver MF , SchnollSH: Opioid treatment of chronic pain in patients with addiction.J. Pain Palliat. Care Pharmacother.16(3) , 5–26 (2002).
   PubMedGoogle Scholar
• Weaver MF , SchnollSH: Abuse liability in opioid therapy for pain treatment in patients with an addiction history.Clin. J. Pain18(Suppl. 4) , S61–S69 (2002).
   PubMed Web of Science ®Google Scholar
• Breivik H : Opioids in cancer and chronic non-cancer pain therapy-indications and controversies.Acta Anaesthesiol. Scand.45(9) , 1059–1066 (2001).
   PubMed Web of Science ®Google Scholar
• Jackson KC 2nd, Mannes A: Persistent pain management for improved quality of life. J. Am. Pharm. Assoc.43(5 Suppl. 1) , S30–S31 (2003).
   Google Scholar
• Fishbain DA : Medico–legal rounds: Medico–legal issues and breaches of “standards of medical care” in opioid tapering for alleged opioid addiction.Pain Med.3(2) , 135–142; discussion 143–146 (2002).
   PubMed Web of Science ®Google Scholar
• Porter-Williamson K , HeffernanE, Von Gunten CF: Pseudoaddiction. J. Palliat. Med.6(6) , 937–939 (2003).
   PubMedGoogle Scholar
• Elander J , LusherJ, BevanD, TelferP, BurtonB: Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence.J. Pain Symptom Manage.27(2) , 156–169 (2004).
   PubMed Web of Science ®Google Scholar
• Lusher J , ElanderJ, BevanD, TelferP, BurtonB: Analgesic addiction and pseudoaddiction in painful chronic illness.Clin. J. Pain22(3) , 316–324 (2006).
   PubMed Web of Science ®Google Scholar
• Cleeland CS : Pain and symptom management. In: Manual of Clinical Oncology (6th Edition). Love RR (Ed.). Springer-Verlag, Berlin, Germany, 556–569 (1994).
   Google Scholar
• Breitbart W , McDonaldM, RosenfeldB et al.: Pain in ambulatory AIDS patients. I: pain characteristics and medical correlates.Pain68 , 315–321 (1996).
   PubMed Web of Science ®Google Scholar
• Breitbart W , PassikS, McDonaldMV et al.: Patient-related barriers to pain management in ambulatory AIDS patients.Pain76(1–2) , 9–16 (1998).
   PubMed Web of Science ®Google Scholar
• Okuyama T , WangXS, AkechiT et al.: Adequacy of cancer pain management in a Japanese Cancer Hospital.Jpn J. Clin. Oncol.34(1) , 37–42 (2004).
   PubMed Web of Science ®Google Scholar
• Passik SD , KirshKL, DonaghyK, PortenoyRK: Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse.Clin. J. Pain22(2) , 173–181 (2006).
   PubMed Web of Science ®Google Scholar
• Starck PL , SherwoodGD, Adams-McNeillJ: Pain management outcomes: issues for advanced practice nurses.Int. J. Adv. Nurs. Pract.4(1) , (2000).
   Google Scholar
• Zimmerman P , WittchenHU, HoflerM, PfisterH, KesslerRC, LiebR: Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults.Psychol. Med.33(7) , 1211–1222 (2003).
   PubMed Web of Science ®Google Scholar
• Kirsh KL , JassC, BennettDS, HagenJE, PassikSD: Initial development of a survey tool to detect issues of chemical coping in chronic pain patients.Palliat. Support. Care5 , 219–226 (2007).
   PubMedGoogle Scholar
• Passik SD , KirshKL, WhitcombLA, DickersonP, TheobaldDE: Pain clinicians‘ rankings of aberrant drug-taking behaviors.J. Pain Palliat. Care Pharmacother.16(4) , 39–49 (2002).
   PubMedGoogle Scholar
• Cicero TJ , InciardiJA, SurrattH: Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States.Drug Alcohol Depend.91(2–3) , 115–120 (2007).
   PubMed Web of Science ®Google Scholar
• Webster LR , DoveB: Avoiding Opioid Abuse While Managing Pain: A Guide for Practitioners (1st Edition). Sunrise River Press, North Branch, MN, USA (2007).
   Google Scholar

▪ Websites

• WHO: Cancer pain relief, 2nd edition: with a guide to opioid availability. WHO, Geneva, Switzerland (1996) http://whqlibdoc.who.int/publications/9241544821.pdf (Accessed 4thNovember2011)
   Google Scholar
• Jacox A, Carr DB, Payne ZR, Berde CP, Breitbart W, Cain J: Management of cancer pain. Clinical Practice Guideline No. 9. AHCPR Pub. No. 94-0592. Rockville: Agency for Health Care Policy and Research, US Department of Health and Human Services, Public Health Service (1994) www.ncbi.nlm.nih.gov/books/NBK16522/ (Accessed 4thNovember2011)
   Google Scholar